Celgene Corporation (CELG)

Celgene Corporation (CELG $108.24)
- View CELG Profile
- View Questions on CELG

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Celgene Corporation (CELG $108.24)
- View CELG Profile
- View Questions on CELG
Bristol-Myers Squibb Company (BMY $42.82)
- $42.82 P/E (TTM): 17.43X Cap: $87.15B
- View BMY Profile
- View Questions on BMY

Q: Good morning team, with my celg shares gone, replaced with bmy and bmy.rt , my question is what to do with the bmy rights. Sell , hold or what will they may be worth in the future? Any thoughts?

Thanks, Michael

Read Answer Asked by Michael on November 25, 2019

Amgen Inc. (AMGN $292.09)
- $292.09 P/E (TTM): 23.79X Cap: $157.25B
- View AMGN Profile
- View Questions on AMGN
Biogen Inc. (BIIB $149.13)
- $149.13 P/E (TTM): 14.4X Cap: $21.86B
- View BIIB Profile
- View Questions on BIIB
Celgene Corporation (CELG $108.24)
- View CELG Profile
- View Questions on CELG

Q: Which biopharma company is the “Best of Breed” to hold for at least 10 years. I am focused on total return over the holding period rather than dividend yield. Also please provide your views on Biogen, Amgen and Celgene. Thanks,

Read Answer Asked by Rino on November 07, 2019

Amgen Inc. (AMGN $292.09)
- $292.09 P/E (TTM): 23.79X Cap: $157.25B
- View AMGN Profile
- View Questions on AMGN
Celgene Corporation (CELG $108.24)
- View CELG Profile
- View Questions on CELG
Merck & Company Inc. (MRK $87.03)
- $87.03 P/E (TTM): 13.57X Cap: $217.38B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $24.50)
- $24.50 P/E (TTM): 13.18X Cap: $139.29B
- View PFE Profile
- View Questions on PFE

Q: Based on my portfolio review, I need to increase my pharmaceutical weighing. Although you do not follow US companies closely, could you give me your best recommendations for 3 US pharmaceutical Companies. My only holding at the moment is Pfizer. Could you give me your opinion on this company please?

Read Answer Asked by jacques on October 09, 2019